Latest News and Press Releases
Want to stay updated on the latest news?
-
RALEIGH, N.C., Nov. 12, 2014 (GLOBE NEWSWIRE) -- LipoScience, Inc. (Nasdaq:LPDX) today announced its financial results for the third quarter ended September 30, 2014. Third Quarter 2014...
-
RALEIGH, N.C., Oct. 15, 2014 (GLOBE NEWSWIRE) -- LipoScience, Inc. (Nasdaq:LPDX) today announced that the Federal Trade Commission has granted early termination of the waiting period under the...
-
Acquisition Price of $5.25 Per Share in All Cash Transaction NMR LipoProfile test expands LabCorp's offering of personalized diagnostic tests BURLINGTON, N.C., Sept. 25, 2014 (GLOBE NEWSWIRE) --...
-
Achieves Second Quarter Revenue Guidance Healthcore Study Provides Compelling Data on Reduction in Cardiovascular Disease Risk and Events RALEIGH, N.C., Aug. 12, 2014 (GLOBE NEWSWIRE) --...
-
RALEIGH, N.C., Aug. 4, 2014 (GLOBE NEWSWIRE) -- LipoScience, Inc. (Nasdaq:LPDX) today announced that it will release its second quarter 2014 financial results after the market close on Tuesday, August...
-
RALEIGH, N.C., May 12, 2014 (GLOBE NEWSWIRE) -- LipoScience, Inc. (Nasdaq:LPDX), a diagnostic company pioneering a new field of personalized nuclear magnetic resonance (NMR) diagnostics to advance the...
-
RALEIGH, N.C., May 5, 2014 (GLOBE NEWSWIRE) -- In a proactive effort to manage its cash, LipoScience, Inc. (Nasdaq:LPDX) today announced a reduction in workforce. This announcement represents the...
-
RALEIGH, N.C., April 28, 2014 (GLOBE NEWSWIRE) -- LipoScience, Inc. (Nasdaq:LPDX) today announced that it will release its first quarter 2014 financial results after the market close on Monday, May...
-
RALEIGH, N.C., March 28, 2014 (GLOBE NEWSWIRE) -- LipoScience, Inc. (Nasdaq:LPDX) today announced the termination of its relationship with Health Diagnostics Laboratory, Inc. ("HDL Inc."), one of its...
-
RALEIGH, N.C., March 10, 2014 (GLOBE NEWSWIRE) -- LipoScience, Inc. (Nasdaq:LPDX), a diagnostic company pioneering a new field of personalized nuclear magnetic resonance (NMR) diagnostics to advance...